Solt DB Invited to Participate in Ascender Bootcamp

PITTSBURGH, PA -- The finch has bootstrapped its way to bootcamp n@.

Solt DB was invited to participate in the Pre-Incubation Bootcamp for Ascender, one of Pittsburgh's early-stage startup incubators. This is the final step for being accepted into the 2023-24 incubator class.

Simply completing the application helped us to refine the pitch for our dynamic investment research platform, which is more valuable that the static investment research most investors are stuck with. Importantly, our unique business model will allow us to fund our core mission of fostering an open and distributed future for living tech with high-quality databases, data visualizations, and more.

Participating in the bootcamp program during April and May will help us to expand our network in the Pittsburgh startup community and further refine our pitch -- just in time for our Beta 2.0 launch on our own website (living.tech). Based on our industry knowledge and early subscriber demographic data, we think there's a path to targeting a unique group of individual investors that aren't being served today. We're also in early discussions to create a higher net-worth service for family offices. Exploring these initiatives would be part of our focus if accepted into the incubator.

Ascender Bootcamp culminates with a pitch on May 6. If there's a good fit between our roadmap and Ascender's expertise, then Solt DB could earn a spot in the 2023-24 incubator class starting in June.

No matter the final decision, this has been and should continue to be a great experience for the finch during what's shaping up to be a pivotal year.

We look forward to updating you soon. In the meantime, read more about Ascender.

‍

About Solt DB

Solt DB is a biotech equities research firm. The finch helps scientists learn about investing and the business of biotech.

Paying members have access to our investment research, price modeling, and real-money investment portfolio that shows how we put our strategic analysis into action. Founded as a public benefit company, Solt DB also publishes free articles and data visualizations analyzing nerdy topics in the bioeconomy. Our long-term goal is to build an open-source database of every global biotech company, past and present, to enable the most granular business intelligence, job searches, sales pipeline buildouts, and more across all six biotech sectors. The company database will relaunch in 2026.